First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.
Jin G ChoiAaron N WinnM Reza SkandariMelissa I FrancoErin M StaabJason T AlexanderWen WanMengqi ZhuElbert S HuangLouis H PhilipsonNeda LaiteerapongPublished in: Annals of internal medicine (2022)
American Diabetes Association.